ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 20 mg - lenalidomide

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - docetaxel - תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - אבקה וממס להכנת תמיסה להזרקה - etanercept 25 mg/vial - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg/ml - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg/ml - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

ישראל - עברית - Ministry of Health

euromar ltd - tilmicosin as phosphate/aqueous 250 mg/ml - solution - pigs: for the treatment of respiratory infections in pig herds associated with mycoplasma hyopneumoniae pasteurella multocida actinobacillus pleuropneumoniae and other organisms susceptible to tilmicosin. chickens: (except hens producing eggs for human consumption): for the treatment of respiratory infections in chicken flocks associated with mycoplasma gallisepticum and m. synoviae. calves: for the treatment of bovine respiratory disease associated with pasteurella haemolytica p. multocida mycoplasma bovis m. dispar and other organisms susceptible to tilmicosin.turkeys: for the treatment of outbreaks of respiratory disease in turkey flocks associated with mycoplasma gallisepticum and m.synoviae.

ישראל - עברית - Ministry of Health

euromar ltd - tilmicosin as phosphate/aqueous 250 mg/ml - solution - pigs: for the treatment of respiratory infections in pig herds associated with mycoplasma hyopneumoniae pasteurella multocida actinobacillus pleuropneumoniae and other organisms susceptible to tilmicosin. chickens: (except hens producing eggs for human consumption): for the treatment of respiratory infections in chicken flocks associated with mycoplasma gallisepticum and m. synoviae. calves: for the treatment of bovine respiratory disease associated with pasteurella haemolytica p. multocida mycoplasma bovis m. dispar and other organisms susceptible to tilmicosin.turkeys: for the treatment of outbreaks of respiratory disease in turkey flocks associated with mycoplasma gallisepticum and m.synoviae.

ישראל - עברית - Ministry of Health

אלפא-נטו בע"מ - רופא

ישראל - עברית - Ministry of Health

mego afek ac ltd. - כלל האוכלוסיה - primary lymphedema, secondary lymphedema, venous insufficiency, venous disorders & dysfunction of the muscle pump

ישראל - עברית - Ministry of Health

euromar ltd - tilmicosin as phosphate/aqueous - תמיסה - tilmicosin as phosphate/aqueous 250 mg/ml